pone.0262198.s013.pdf (23.1 kB)
Kaplan-Meier curve for GZMB expression stratified by median in 177 CMS2 tumors with low T-effector score from the GSE39582 dataset for RFS.
journal contribution
posted on 2021-12-31, 18:45 authored by Anneleen Daemen, Akshata R. Udyavar, Thomas Sandmann, Congfen Li, Linda J. W. Bosch, William O’Gorman, Yijin Li, Amelia Au-Yeung, Chikara Takahashi, Omar Kabbarah, Richard Bourgon, Priti Hegde, Carlos Bais, Meghna Das ThakurA T-effector score, excluding GZMB, below the mean score in the full cohort is considered low. The p-value corresponds to a log-rank test.
(PDF)
History
Usage metrics
Categories
Keywords
year survival ratetargeted treatment evaluationprovides scientific rationaleincluded 1062 patientsconsensus molecular subtypescms2 tumor cellsbiomarker defined subpopulationspropagates stage iidisease 8217adjuvant stage iivalidation cohort gse39582immune 8212high granzyme bdisease specific roleaccurately capture highsignificant prognostic impactcell independent fashioncancer genome atlasalternative gzmb sourceperformed expression profilingrisk crc patientsindependent cohortstage iiimetastatic diseasetranscriptomic profilingspecific implicationsimmune componentcell linesrisk stratificationrisk crcrisk classificationresectable highimprove highfuture highxlink ">work furthersunderlying biologystill needretrospective analysisrelated deathsprospective threeprognostic signatureprognostic biologyleading causelarge datasetfound gzmbendogenously expressedeffector genesclinically validatedalthough robust
Licence
Exports
RefWorksRefWorks
BibTeXBibTeX
Ref. managerRef. manager
EndnoteEndnote
DataCiteDataCite
NLMNLM
DCDC